Lack of sex differences in striatal dopamine D2 receptor binding in drug-naive schizophrenic patients: an IBZM-SPECT study

Psychiatry Res. 2004 Jan 15;130(1):79-84. doi: 10.1016/j.pscychresns.2003.05.001.

Abstract

Differences in antipsychotic treatment response, clinical course and outcome of schizophrenia could be related to gender-related cerebral differences in anatomy and function. The aim of the study was to assess sex differences in the striatal dopamine D2 receptor binding in 15 drug-naive schizophrenic patients (seven males, eight females) using (123)I-IBZM single photon emission computed tomography. Basal ganglia/frontal cortex (BG/FC) uptake ratios were obtained. No significant differences were found in global, left and right BG/FC ratios or laterality indices between males and females. No correlation was found between BG/FC ratios and age, duration of illness or scores on symptom rating scales. Our data indicate a lack of sex differences in striatal D2 receptor binding in drug-naive schizophrenic patients and do not support previous reports of left lateralized striatal asymmetry in male schizophrenic patients.

MeSH terms

  • Adult
  • Basal Ganglia / metabolism
  • Benzamides* / pharmacokinetics
  • Binding, Competitive
  • Contrast Media / pharmacokinetics
  • Corpus Striatum / metabolism*
  • Female
  • Frontal Lobe / metabolism
  • Functional Laterality / physiology
  • Humans
  • Male
  • Pyrrolidines* / pharmacokinetics
  • Receptors, Dopamine D2 / metabolism*
  • Schizophrenia / metabolism*
  • Sex Factors
  • Tomography, Emission-Computed, Single-Photon*

Substances

  • Benzamides
  • Contrast Media
  • Pyrrolidines
  • Receptors, Dopamine D2
  • 3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide